F1‐02‐02: Genetic Influence on Levels of Targeted Metabolites Associated with Alzheimer’s Disease
Year: 2016
Type: article
Source: Alzheimer s & Dementia
Authors: Sungeun Kim, Jon B. Toledo, Kwangsik Nho, Shannon L. Risacher, Li Shen, J. Will Thompson, Lisa St. John Williams, Jessie Tenenbaum, Xianlin Han, Rebecca A. Baillie, Madhav Thambisetty, Ramon Casanova, Sudhir Varma, Cristina Legido-Quigley, Siamak Mahmoudiandehkordi, Alison Motsinger-Reif, Hongjie Zhu, Gabi Kastenmüller, Karsten Suhre, Guido Dallmann, Kristaps Klavins, Therese Koal, M Arthur Moseley, John Q. Trojanowski, Leslie M. Shaw, Michael W. Weiner, Murali Doraiswamy, Rima F. Kaddurah-Daouk, Andy J. Saykin, Alzheimer’s Disease Neuroimaging Initiative
Institutions: Indiana University School of Medicine, University of Pennsylvania, Duke University, Sanford Burnham Prebys Medical Discovery Institute, Rosa (United States), National Institute on Aging, Wake Forest University Health Sciences, Wake Forest University, King's College London, North Carolina State University, Helmholtz Munich, Weill Cornell Medical College in Qatar, Biocrates Life Sciences (Austria), University of California, San Francisco, Duke Medical Center, Alzheimer’s Disease Neuroimaging Initiative
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2535212189
